Category Archives: Interview
DOAJ—A Quality Control System for Open Access Publishers
The Directory of Open Access Journals (DOAJ)—a community-curated list of open access journals—was launched in 2003 at Lund University, Sweden, with the aim of promoting high quality, peer-reviewed, open access material. Nowadays, operated by IS4OA, a non-profit company registered in the United Kingdom, DOAJ contains over 10,000 open access journals covering all research fields, and […]
More InfoNon-Coding RNAs and Epigenetics in Cancer: An interview with Dr. Carlo Croce
One of the most unexpected and fascinating discoveries in oncology over the past decade has been the interplay between abnormalities in protein-coding genes and non-coding RNAs (ncRNAs), which are causally involved in cancer initiation, progression, and dissemination. Although, to date, the most studied non-coding RNAs (ncRNAs) are microRNAs (miRNAs), the importance of long non-coding RNAs […]
More InfoMeet and Greet: Arjen Hoekstra, Editor-in-Chief of Water
Prof. Arjen Hoekstra is a professor of Water Management at the University of Twente, in Enschede, the Netherlands. Throughout his career he has led a variety of interdisciplinary research projects and acted as an advisor to governments, civil society organizations, companies and multilateral institutions like UNESCO and the World Bank. Prof. Hoekstra was the first […]
More InfoNon-Coding RNAs in Cancer: An Interview with Dr. Martin Pichler
We are pleased to post an interview with Professor Martin Pichler, who is the Collection Editor for the International Journal of Molecular Sciences Topical Collection of “Regulation by Non-Coding RNAs” [1]. You can also find the interview published here in IJMS. Professor Martin Pichler, MD, MSc, received his MD at the Medical University of Graz, […]
More InfoQ&A I: Authors, Submission and Peer-Review
We always enjoy opportunities to get direct face-to-face feedback from authors and readers, and the recent open access week was an excellent opportunity. We were asked a number of interesting questions that we thought would merit a wider audience. This post kicks off a short series including a selection of the best questions. We are […]
More InfoInterview with Gerhard Litscher, Editor-in-Chief of Medicines
Professor Gerhard Litscher, Editor-in-Chief of the journal Medicines, received his Doctor of technical sciences at the Graz University of Technology and a Doctor of medical sciences at the Medical University of Graz. For more than 16 years, he has been investigating acupuncture with modern equipment. He has published more than 170 PubMed/SCIE-listed papers on the […]
More InfoInterview with Eric Freed, Editor-in-Chief of Viruses
Dr. Eric Freed, Editor-in-Chief of the journal Viruses, received his Ph.D. in 1990 with Rex Risser and Howard Temin at the University of Wisconsin-Madison, where he investigated the function of the murine leukemia virus and HIV envelope glycoproteins in membrane fusion and virus entry. He joined Malcolm Martin at the National Institute of Allergy and Infectious […]
More InfoBrain Jelly – An Organic, Brain-Like Computer without Circuits or Logic Gates
The human brain is the most powerful computer the world has ever seen. With its 86 billion neurons [1], less than originally thought (~100 billion, a myth of unknown origin [2]), the human brain is still at the top of the list and capable of remarkable feats, not only as far as computing power is […]
More InfoControlling Sugar Intake: A Platform to Predict Glycosylation for Therapeutic Antibodies
Glycoproteins are formed through protein glycosylation, the post-translational addition and processing of covalently bound oligosaccharide chains. Variations in the glycoform of proteins result from multiple factors in this process, such as enzyme and substrate availability, and these differences can influence the stability and biological function of the protein1.
More InfoLeon Terstappen on Circulating Tumor Cells: Biology and Technology
Tumor metastases cause ninety percent of cancer deaths, and occur when cells detach from a primary tumor and form new malignancies elsewhere. This process involves circulating tumor cells (CTC) which intravasate and extravasate (enter and exit the blood vessels) allowing migration to other parts of the body.
More Info